Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
Filed with SSE · · 3 pages · Chinese
Release
Aurisco Pharmaceutical Co. Ltd. on 6ix
Earlier from Aurisco Pharmaceutical
- Announcement on Not Revising Downward Conversion Price of ""Aurisco Convertible Bonds"
- Announcement on Adjusting the Conversion Price of "Aurisco Convertible Bonds" Due to Implementation of Dividend Distribution
- Indicative Announcement on ""Aurisco Convertible Bonds"" Expected to Meet Conditions for Revising Conversion Price
- Indicative Announcement on Suspending Conversion of "Aurisco Convertible Bonds" When Implementing Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Approval by the Company
Later from Aurisco Pharmaceutical
- Correction Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiary
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Announcement on Passing GMP Compliance Inspection for Drugs
- Announcement on Inclusion of the Company's Main Products in the "National Essential Medicines List (2026 Edition)"
- Announcement on 2026 Interest Payment for "Aurisco Convertible Bonds"
Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.
Follow Aurisco Pharmaceutical